entertainment -WSS

entertainment

author：Wikipedia 2025-08-11 07:58:30 - browse：64717

a stethoscope and money – hospitals and health insurance coverage from STAT — Bright Health is officially leaving the health insurance market. The company has agreed to sell its Medicare Advantage plans to Molina Healthcare. Adobe

Bright Health Group has agreed to sell its Medicare Advantage plans to its publicly traded peer Molina Healthcare.

Regulators must approve the deal. But the pending sale of its Medicare Advantage business means the financially distressed Bright has exited the health insurance market that the company was founded on. It will solely operate roughly 70 physician clinics located in California, Texas, and Florida.

Molina agreed to pay $600 million for Bright’s 125,000 California Medicare Advantage enrollees, which equates to about $4,800 for each person. The federal government paid insurance companies almost $12,000, on average, for each MA enrollee in 2022. Molina said in a news release that Bright’s current book of business generates $1.8 billion of revenue, or more than $14,000 for each member.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Brain MRIs reveal impact of 'toxic stress' on Black children

WSS

As health system earnings go up, health insurance stocks go down

Recent heat wave in the Mediterranean caused by climate change: Study

Nevada Republican Sam Brown launching another Senate bid, teeing up marquee race

Is it ever OK for doctors to lie to their patients?

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Recent heat wave in the Mediterranean caused by climate change: Study

hotspot

entertainment

entertainment

Activists slam private health insurers over coverage restrictions

Chemotherapy before breast cancer surgery might fuel metastasis

Malaria cases in Florida and Texas: Here’s what you need to know

Crowdfunding for medical bills sidesteps core problem, author says

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Cancer drug shortages should be causing more outrage

Novel spinal cord stimulator treats paralysis without surgery

Affirmative action in medical school literally saved lives

Class action alleges UnitedHealth concealed DOJ probe

hotspot

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Sepsis can kill a child within hours. Here's how hospitals are fighting back

AI for drug discovery: Experts on separating hype from reality

Pandemic and All Hazards Preparedness Act needs lean update

Biden’s NIH nominee is languishing in Congress

Pandemic and All Hazards Preparedness Act needs lean update

explore

hotspot

focus

focus